Genetic Characterization and Prognostic Relevance of Acquired Uniparental Disomies in Cytogenetically Normal Acute Myeloid Leukemia

被引:18
|
作者
Walker, Christopher J. [1 ]
Kohlschmidt, Jessica [1 ,2 ]
Eisfeld, Ann-Kathrin [1 ]
Mrozek, Krzysztof [1 ]
Liyanarachchi, Sandya [1 ]
Song, Chi [3 ]
Nicolet, Deedra [1 ,2 ]
Blachly, James S. [1 ]
Bill, Marius [1 ]
Papaioannou, Dimitrios [1 ]
Oakes, Christopher C. [1 ]
Giacopelli, Brian [1 ]
Genutis, Luke K. [1 ]
Maharry, Sophia E. [1 ]
Orwick, Shelley [1 ]
Archer, Kellie J. [1 ,3 ]
Powell, Bayard L. [4 ]
Kolitz, Jonathan E. [5 ]
Uy, Geoffrey L. [6 ]
Wang, Eunice S. [7 ]
Carroll, Andrew J. [8 ]
Stone, Richard M. [9 ]
Byrd, John C. [1 ]
de la Chapelle, Albert [1 ]
Bloomfield, Clara D. [1 ]
机构
[1] Ohio State Univ, Ctr Comprehens Canc, Biomed Res Tower,Room 894,460 W 12th Ave, Columbus, OH 43210 USA
[2] Ohio State Univ, Ctr Comprehens Canc, Alliance Stat & Data Ctr, Columbus, OH 43210 USA
[3] Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH 43210 USA
[4] Wake Forest Baptist Comprehens Canc Ctr, Winston Salem, NC USA
[5] Zucker Sch Med Hofstra Northwell, Monter Canc Ctr, Lake Success, NY USA
[6] Washington Univ, Sch Med St Louis, Siteman Canc Ctr, St Louis, MO 63110 USA
[7] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
[8] Univ Alabama Birmingham, Birmingham, AL USA
[9] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
GROUP-B; DOSE CYTARABINE; CEBPA MUTATIONS; AGE; 60; CANCER; ADULTS; IMPACT; AML; CHEMOTHERAPY; NUMBER;
D O I
10.1158/1078-0432.CCR-19-0725
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Uniparental disomy (UPD) is a way cancer cells duplicate a mutated gene, causing loss of heterozygosity (LOH). Patients with cytogenetically normal acute myeloid leukemia (CN-AML) do not have microscopically detectable chromosome abnormalities, but can harbor UPDs. We examined the prognostic significance of UPDs and frequency of LOH in patients with CN-AML. Experimental Design: We examined the frequency and prognostic significance of UPDs in a set of 425 adult patients with de novo CN-AML who were previously sequenced for 81 genes typically mutated in cancer. Associations of UPDs with outcome were analyzed in the 315 patients with CN-AML younger than 60 years. Results: We detected 127 UPDs in 109 patients. Most UPDs were large and typically encompassed all or most of the affected chromosome arm. The most common UPDs occurred on chromosome arms 13q (7.5% of patients), 6p (2.8%), and 11p (2.8%). Many UPDs significantly cooccurred with mutations in genes they encompassed, including 13q UPD with FLT3-internal tandem duplication (FLT3-ITD; P < 0.001), and 11p UPD with WT1 mutations (P = 0.02). Among patients younger than 60 years, UPD of 11p was associated with longer overall survival (OS) and 13q UPD with shorter disease-free survival (DFS) and OS. In multivariable models that accounted for known prognostic markers, including FLT3-ITD and WT1 mutations, UPD of 13q maintained association with shorter DFS, and UPD of 11p maintained association with longer OS. Conclusions: LOH mediated by UPD is a recurrent feature of CN-AML. Detection of UPDs of 13q and 11p might be useful for genetic risk stratification of patients with CN-AML.
引用
收藏
页码:6524 / 6531
页数:8
相关论文
共 50 条
  • [1] Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysis
    Bullinger, L.
    Kroenke, J.
    Schoen, C.
    Radtke, I.
    Urlbauer, K.
    Botzenhardt, U.
    Gaidzik, V.
    Cario, A.
    Senger, C.
    Schlenk, R. F.
    Downing, J. R.
    Holzmann, K.
    Doehner, K.
    Doehner, H.
    LEUKEMIA, 2010, 24 (02) : 438 - 449
  • [2] Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysis
    L Bullinger
    J Krönke
    C Schön
    I Radtke
    K Urlbauer
    U Botzenhardt
    V Gaidzik
    A Carió
    C Senger
    R F Schlenk
    J R Downing
    K Holzmann
    K Döhner
    H Döhner
    Leukemia, 2010, 24 : 438 - 449
  • [3] PROGNOSTIC RELEVANCE OF ACQUIRED STRUCTURAL GENETIC ABNORMALITIES IN ACUTE MYELOID LEUKEMIA
    Nibourel, O.
    Roumier, C.
    Guihard, S.
    Quentin, S.
    Geffroy, S.
    Alberdi, A.
    Ben Abdelali, R.
    Renneville, A.
    Berthon, C.
    Celli-Lebras, K.
    Dombret, H.
    Soulier, J.
    Preudhomme, C.
    Cheok, M.
    HAEMATOLOGICA, 2013, 98 : 276 - 276
  • [4] The Prognostic Relevance of BAALC and ERG Expression Levels in Cytogenetically Normal Pediatric Acute Myeloid Leukemia
    Salah Aref
    Tawfik Al Khodary
    Tarek Abou Zeed
    Amre El Sadiek
    Nadia El Menshawy
    Rasha Al Ashery
    Indian Journal of Hematology and Blood Transfusion, 2015, 31 : 21 - 28
  • [5] The Prognostic Relevance of BAALC and ERG Expression Levels in Cytogenetically Normal Pediatric Acute Myeloid Leukemia
    Aref, Salah
    Al Khodary, Tawfik
    Abou Zeed, Tarek
    El Sadiek, Amre
    El Menshawy, Nadia
    Al Ashery, Rasha
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2015, 31 (01) : 21 - 28
  • [6] Molecular prognostic factors in cytogenetically normal acute myeloid leukemia
    Walker, Alison
    Marcucci, Guido
    EXPERT REVIEW OF HEMATOLOGY, 2012, 5 (05) : 547 - 558
  • [7] Cytogenetically normal acute myeloid leukemia
    Buechner, Thomas
    Berdel, Wolfgang E.
    Kienast, Joachim
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (06): : 651 - 651
  • [8] Gene expression with prognostic implications in cytogenetically normal acute myeloid leukemia
    Baldus, Claudia D.
    Bullinger, Lars
    SEMINARS IN ONCOLOGY, 2008, 35 (04) : 356 - 364
  • [9] Prognostic significance of BAALC expression in cytogenetically normal acute myeloid leukemia
    Chopra, Anita
    Verma, Deepak
    Kumar, Rajive
    Singh, Jay
    Ali, Shadab
    Bakhshi, Sameer
    Sharma, Atul
    Palanichamy, Jayanth Kumar
    Sharawat, Surender Kumar
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 78 - 79
  • [10] Genetic Markers in Older Cytogenetically Normal Acute Myeloid Leukemia Patients
    Becker, H.
    Marcucci, G.
    Bloomfield, C. D.
    ANNALS OF HEMATOLOGY, 2013, 92 : S30 - S33